Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-18 Sale |
2025-02-21 6:10 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY |
4,370 | $11.96 | $52,278 | 444,763 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-21 6:08 pm |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL |
4,646 | $11.96 | $55,580 | 168,470 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-21 6:05 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
12,048 | $11.96 | $144,130 | 2,084,675 (Indirect Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 4:06 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
30,000 | $13.31 | $399,339 | 2,034,015 (Indirect Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 4:36 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
10,554 | $13.21 | $139,420 | 1,909,723 (Indirect Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 4:34 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
2,206 | $13.21 | $29,142 | 2,153,027 (Indirect Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 4:32 pm |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL |
3,165 | $13.21 | $41,810 | 114,116 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 4:30 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY |
2,602 | $13.21 | $34,373 | 343,133 (Direct) |
View |
| 2024-11-08 Sale |
2024-11-12 4:57 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
28,255 | $16.15 | $456,223 | 2,057,535 (Indirect Direct) |
View |
| 2024-11-07 Sale |
2024-11-08 4:15 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
11,245 | $16.03 | $180,287 | 2,085,790 (Indirect Direct) |
View |
| 2024-10-31 Sale |
2024-11-04 5:24 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
500 | $16.02 | $8,010 | 2,097,035 (Indirect Direct) |
View |
| 2024-09-10 Sale |
2024-09-12 4:48 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
30,000 | $14.22 | $426,675 | 2,097,535 (Indirect Direct) |
View |
| 2024-08-16 Sale |
2024-08-19 6:12 pm |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL |
3,202 | $14 | $44,825 | 117,281 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-19 6:07 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY |
2,633 | $14 | $36,860 | 345,735 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-19 5:59 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
2,232 | $14 | $31,246 | 2,225,233 (Indirect Direct) |
View |
| 2024-08-16 Sale |
2024-08-19 5:53 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
10,681 | $14 | $149,524 | 1,920,277 (Indirect Direct) |
View |
| 2024-07-16 Sale |
2024-07-17 4:53 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
20,000 | $16.01 | $320,226 | 2,121,081 (Indirect Direct) |
View |
| 2024-06-21 Sale |
2024-06-21 7:17 pm |
Day One Biopharmaceuticals Inc. | DAWN | Ramasastry Saira Director |
10,000 | $13.19 | $131,877 | 40,485 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-12 4:29 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
30,000 | $12.62 | $378,588 | 2,141,081 (Indirect Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 6:27 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
7,873 | $16.08 | $126,588 | 1,930,958 (Indirect Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 6:18 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
2,267 | $16.08 | $36,450 | 2,277,465 (Indirect Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 6:15 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY |
2,675 | $16.08 | $43,011 | 348,368 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 6:11 pm |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL |
3,253 | $16.08 | $52,304 | 120,483 (Direct) |
View |
| 2024-05-10 Sale |
2024-05-14 6:13 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
10,000 | $16.37 | $163,743 | 2,164,662 (Indirect Direct) |
View |
| 2024-05-01 Sale |
2024-05-03 6:48 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
79,211 | $17.87 | $1,415,707 | 1,686,326 (Indirect Direct) |
View |
| 2024-05-01 Sale |
2024-05-03 6:44 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY |
60,461 | $17.88 | $1,081,191 | 217,293 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-02-28 7:50 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Merendino Lauren Chief Commercial Officer |
0 | $0 | 666,256 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-21 6:10 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY |
16,875 | $0 | 444,763 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-21 6:08 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL |
12,086 | $0 | 168,470 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-21 6:05 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
31,686 | $0 | 2,084,675 (Direct) |
View |
| 2025-01-15 Option Award |
2025-01-31 4:38 pm |
N/A 2035-01-14 |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY |
268,000 | $0 | 268,000 (Direct) |
View |
| 2025-01-15 Option Award |
2025-01-31 4:36 pm |
N/A 2035-01-14 |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
473,000 | $0 | 473,000 (Direct) |
View |
| 2025-01-15 Option Award |
2025-01-31 4:33 pm |
N/A 2035-01-14 |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL |
149,000 | $0 | 149,000 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 4:36 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
19,999 | $0 | 1,909,723 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 4:34 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
8,686 | $0 | 2,153,027 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 4:32 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL |
8,399 | $0 | 114,116 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 4:30 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY |
10,250 | $0 | 343,133 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 6:12 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL |
8,399 | $0 | 117,281 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 6:07 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY |
10,250 | $0 | 345,735 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 5:59 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
8,686 | $0 | 2,225,233 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 5:53 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
19,999 | $0 | 1,920,277 (Direct) |
View |
| 2024-07-02 Gift |
2024-07-05 6:11 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
241,912 | $0 | 896,640 (Indirect) |
View |
| 2024-05-23 Option Award |
2024-05-28 6:48 pm |
N/A 2034-05-22 |
Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director |
32,335 | $0 | 32,335 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 6:44 pm |
N/A 2034-05-22 |
Day One Biopharmaceuticals Inc. | DAWN | Grossman William Director |
32,335 | $0 | 32,335 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 6:31 pm |
N/A 2034-05-22 |
Day One Biopharmaceuticals Inc. | DAWN | Ramasastry Saira Director |
32,335 | $0 | 32,335 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 6:27 pm |
N/A 2034-05-22 |
Day One Biopharmaceuticals Inc. | DAWN | Nicholson Garry A Director |
32,335 | $0 | 32,335 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 6:24 pm |
N/A 2034-05-22 |
Day One Biopharmaceuticals Inc. | DAWN | Josey John A. Director |
32,335 | $0 | 32,335 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 6:21 pm |
N/A 2034-05-22 |
Day One Biopharmaceuticals Inc. | DAWN | Holles Natalie C. Director |
32,335 | $0 | 32,335 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 6:17 pm |
N/A 2034-05-22 |
Day One Biopharmaceuticals Inc. | DAWN | Gladstone Michael Director |
32,335 | $0 | 32,335 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 6:13 pm |
N/A 2034-05-22 |
Day One Biopharmaceuticals Inc. | DAWN | Dable Habib J Director |
32,335 | $0 | 32,335 (Direct) |
View |
| 2024-05-15 Exercise |
2024-05-17 6:27 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER |
19,999 | $0 | 1,930,958 (Direct) |
View |
| 2024-05-15 Exercise |
2024-05-17 6:18 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D |
8,686 | $0 | 2,277,465 (Direct) |
View |
| 2024-05-15 Exercise |
2024-05-17 6:15 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY |
10,250 | $0 | 348,368 (Direct) |
View |
| 2024-05-15 Exercise |
2024-05-17 6:11 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL |
8,399 | $0 | 120,483 (Direct) |
View |